Your browser doesn't support javascript.
loading
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.
Gaborit, Benjamin; Dailly, Eric; Vanhove, Bernard; Josien, Régis; Lacombe, Karine; Dubee, Vincent; Ferre, Virginie; Brouard, Sophie; Ader, Florence; Vibet, Marie-Anne; Le Thuaut, Aurélie; Danger, Richard; Flet, Laurent; Omnes, Anne; Berly, Laetitia; Chiffoleau, Anne; Jobert, Alexandra; Duvaux, Odile; Raffi, François.
Afiliação
  • Gaborit B; Department of Infectious Disease, Nantes University Hospital, Nantes, France.
  • Dailly E; INSERM CIC1413, Nantes University Hospital, Nantes, France.
  • Vanhove B; Clinical Pharmacology Department, CHU Nantes, Nantes, France.
  • Josien R; Xenothera, Nantes, France.
  • Lacombe K; Laboratoire d'Immunologie, CIMNA, CHU Nantes, Nantes, France.
  • Dubee V; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, ITUN, CHU Nantes, Nantes, France.
  • Ferre V; Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, AP-HP, Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, Paris, France.
  • Brouard S; Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire d'Angers, Angers, France.
  • Ader F; INSERM CIC1413, Nantes University Hospital, Nantes, France.
  • Vibet MA; Virology Laboratory University Hospital, Nantes, France.
  • Le Thuaut A; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, ITUN, CHU Nantes, Nantes, France.
  • Danger R; Centre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France.
  • Flet L; Département des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France.
  • Omnes A; CHU Nantes, Sponsor Department, Nantes, France.
  • Berly L; CHU Nantes, Sponsor Department, Nantes, France.
  • Chiffoleau A; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, ITUN, CHU Nantes, Nantes, France.
  • Jobert A; CHU Nantes, Pharmacy Department, Nantes, France.
  • Duvaux O; CHU Nantes, Sponsor Department, Nantes, France.
  • Raffi F; CHU Nantes, Sponsor Department, Nantes, France.
Antimicrob Agents Chemother ; 65(9): e0123721, 2021 08 17.
Article em En | MEDLINE | ID: mdl-34181475
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França